论文部分内容阅读
目的:探讨厄贝沙坦联合钙离子拮抗剂治疗老年2型糖尿病肾病合并高血压的临床效果。方法:选取我院2012年9月~2014年9月收治的老年2型糖尿病肾病合并高血压患者77例,随机分为两组,对比两组患者临床疗效。结果:观察组患者血压、尿微量蛋白等指标均明显低于对照组(P<0.05)差异有统计学意义。结论:厄贝沙坦联合钙离子拮抗剂治疗老年2型糖尿病肾病合并高血压临床疗效确切,能够有效降低患者BP、u—ALB、HbA等指标,并在降压过程中保护肾脏功能,值得临床应用推广。
Objective: To investigate the clinical efficacy of irbesartan and calcium antagonist in the treatment of elderly type 2 diabetic nephropathy with hypertension. Methods: Seventy-seven elderly patients with type 2 diabetic nephropathy complicated with hypertension admitted to our hospital from September 2012 to September 2014 were randomly divided into two groups, and the clinical efficacy was compared between the two groups. Results: The indexes of blood pressure and urine microalbumin in the observation group were significantly lower than those in the control group (P <0.05). Conclusion: Irbesartan combined with calcium ion antagonist in elderly patients with type 2 diabetic nephropathy complicated with hypertension is effective, and can effectively reduce BP, u-ALB, HbA and other indicators, and in the process of antihypertensive protection of renal function, it is worth clinical Application promotion.